Simon Allen is a C-level executive with 30+ years of global biotechnology experience spanning multiple technology platforms and therapeutic sectors. Simon specializes in leadership, strategy, operations, drug development, finance, and sell-side business development.
Simon has a strong business acumen, extensive knowledge of developing drugs from invention to market, and ability to focus complex technologies into discrete transactable assets. His lead accomplishments include 27 partnerships, 7 financings, and 6 scientific publications (some including Biosafety Level 3 work). Additional experience gained as an equities analyst covering selected companies within the pharmaceutical and medical device sectors.